6Kondo S, Yoneta A, Yazawa H, et al. Downregulation of CXCR- 2 but not CXCR- 1 expression by human keratinocytes by UVB. J Cell Physiol, 2000,182:366- 370.
7Vandenbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune diseases. Neurochem Res, 2001,26:713- 730.
9Schroder JM, Harder J. Human beta- defensin- 2. Int J Biochem Cell Biol, 1999,31:645- 651.
10Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T- cell- mediated skin disease. Viewpoint. J Cutan Pathol, 2001,28:57- 64.
1Kammer GM,Soter NA,Gibson DJ,et al.Psoriatic arthritis:a clinical,immunologic and HLA study of 100 patients[J].Semin Arthritis Rheum,1979,9(2):75-97.
2Linder R,Hoffmann A,Brunner R.Prevalence of the spondy-loarthritides in patients with uveitis[J].J Rheumatol,2004,31(11):2226-2229.
3Paiva ES,Macaluso DC,Edwards A,et al.Characterisation of uveitis in patients with psoriatic arthritis[J].Ann Rheum Dis,2000,59(1):67-70.
4Keino H,Sakai J,Usui M.Association between HLA-A2 in Japanese psoriasis arthritis and susceptibility to uveitis[J].Graefes Arch Clin Exp Ophthalmol,2003,241(9):777-778.
5Chen ZY,Ainsworth SK,Khan T,et al.Immunoglobulin E in psoriasis evaluated by paper radioimmunosorbent and paper enzyme-immunosorbent tests[J].Acta Derm Venereol,1985,65(1):14-18.
